54
Views
17
CrossRef citations to date
0
Altmetric
Clinical Trials Report

Insight into ACE inhibition in the prevention of cardiac events in stable coronary artery disease: the EUROPA trial

, , , , &
Pages 1037-1046 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tarek AN Ahmed, Ioannis Karalis & J Wouter Jukema. (2011) Emerging drugs for coronary artery disease. From past achievements and current needs to clinical promises. Expert Opinion on Emerging Drugs 16:2, pages 203-233.
Read now

Articles from other publishers (16)

Siva H Yedlapati, Anuradha Mendu, Venkat R Tummala, Sowmith S Maganti, Khurram Nasir & Safi U Khan. (2023) Vaccines and cardiovascular outcomes: lessons learned from influenza epidemics. European Heart Journal Supplements 25:Supplement_A, pages A17-A24.
Crossref
Olga A. Dmitrieva, Olga Iu. Mironova & Victor V. Fomin. (2021) Influenza vaccination and prognosis for patients with high cardiovascular risk. Terapevticheskii arkhiv 93:9, pages 1100-1105.
Crossref
Vasiliki Katsi, Christos-Konstantinos Antoniou, Panagiota Manolakou, Konstantinos Toutouzas & Dimitrios Tousoulis. (2020) What's in a prick? Vaccines and the cardiovascular system. Hellenic Journal of Cardiology 61:4, pages 233-240.
Crossref
C Raina MacIntyre, Abela Mahimbo, Aye M Moa & Michelle Barnes. (2016) Influenza vaccine as a coronary intervention for prevention of myocardial infarction. Heart 102:24, pages 1953-1956.
Crossref
Claudio Borghi, Martino Morbini & Arrigo F.G. Cicero. (2015) Combination therapy in the extended cardiovascular continuum. Journal of Cardiovascular Medicine 16:5, pages 390-399.
Crossref
Pitchai Balakumar & Gowraganahalli Jagadeesh. 2015. Pathophysiology and Pharmacotherapy of Cardiovascular Disease. Pathophysiology and Pharmacotherapy of Cardiovascular Disease 751 806 .
D A Napalkov. (2014) Perindopril - angiotensin-converting enzyme inhibitor is approved for usage. Systemic Hypertension 11:4, pages 75-78.
Crossref
R. Ferrari & C. Ceconi. (2012) PERTINENT: AUTHORS' RETROSPECTIVE. Cardiovascular Research 96:2, pages 204-207.
Crossref
A. K. Ahmed, N. S. Kamath, M. El Kossi & A. M. El Nahas. (2009) The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease. Nephrology Dialysis Transplantation 25:12, pages 3977-3982.
Crossref
Roberto Ferrari, Gabriele Guardigli & Claudio Ceconi. (2010) Secondary Prevention of CAD with ACE Inhibitors: A Struggle Between Life and Death of the Endothelium. Cardiovascular Drugs and Therapy 24:4, pages 331-339.
Crossref
Aris Moschovitis, Rüdiger Simon, Antje Seidenstücker, Volker Klauss, Monika Baylacher, Thomas Lüscher, Tiziano Moccetti, Stephan Windecker, Bernhard Meier & Otto Hess. (2010) Randomised comparison of titanium-nitride-oxide coated stents with bare metal stents: five year follow-up of the TiNOX trial. EuroIntervention 6:1, pages 63-68.
Crossref
R. Ferrari. (2009) Cardiovascular protection by angiotensin-converting enzyme inhibition. European Heart Journal Supplements 11:Suppl E, pages E1-E3.
Crossref
A. Moschovitis & B. Meier. (2009) Are adapted guidelines required for patients with prior bypass surgeries and heart failure in acute myocardial infarction?. European Heart Journal 30:12, pages 1429-1430.
Crossref
Roberto Ferrari & Kim Fox. (2009) Insight into the Mode of Action of ACE Inhibition in Coronary Artery Disease. Drugs 69:3, pages 265-277.
Crossref
Arthur A. Nery, Cleber A. Trujillo, Claudiana Lameu, Katsuhiro Konno, Vitor Oliveira, Antonio C.M. Camargo, Henning Ulrich & Mirian A.F. Hayashi. (2008) A novel physiological property of snake bradykinin-potentiating peptides—Reversion of MK-801 inhibition of nicotinic acetylcholine receptors. Peptides 29:10, pages 1708-1715.
Crossref
R. Ferrari. (2008) Treatment with angiotensin-converting enzyme inhibitors: insight into perindopril cardiovascular protection. European Heart Journal Supplements 10:Suppl G, pages G13-G20.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.